GenomicDAO: Biotechnology company Genetica builds an AI-driven decentralized science platform
The Prime Minister of Vietnam visits Genetica to promote Vietnam's leadership in the Asian biotechnology industry.Author: Genetica
On March 4, during Prime Minister Pham Minh Chinh's visit to the National Innovation Center (NIC), the leading Asian biotechnology company Genetica was honored to welcome the Prime Minister to their laboratory.
The Prime Minister was accompanied by several government officials, including Minister of Defense Phan Van Giang, Minister of Planning and Investment Nguyen Chi Dung, Minister of Foreign Affairs Bui Thanh Son, Minister of Information and Communications Nguyen Manh Hung, Minister of Science and Technology Huynh Thanh Dat, Minister of Social Affairs Dao Ngoc Dung, as well as leaders from central ministries, industry, and Hanoi city.
The Prime Minister visited Genetica's laboratory
During the visit, the Prime Minister emphasized the importance of developing biotechnology as a key driving force for innovation and economic restructuring. Specifically, by 2030, Vietnam aims to be among the top 10 countries in Asia's biotechnology industry, with a highly qualified workforce, strong infrastructure, and ample financial resources.
To help Vietnam achieve this goal by 2030, Genetica aims to accelerate gene decoding and precision medicine through the establishment of an AI-driven decentralized scientific platform, GenomicDAO, benefiting billions of people. "We are proud to have an AI-driven gene decoding platform, a patent-pending Asian genomic decoding chip, and a CLIA-certified genomic laboratory," said Dr. Duyen Bui, co-founder and CSO of Genetica. "These capabilities enable us to revolutionize healthcare for people in Asia and beyond. We firmly believe our work aligns with the Vietnamese government's goal of becoming a biotechnology unicorn by 2030."
About Genetica and GenomicDAO
Genetica is a biotechnology company that offers AI-driven genetic testing services. GenomicDAO is an AI-driven decentralized scientific platform built by Genetica, aimed at uniting billions of people to advance precision medicine.
